2025 annual financial data
Protagonist Therapeutics 2025 Operating margin
Protagonist Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -343.63%.
Operating income was -158,127,000 USD and net income was -130,149,000 USD.
Operating cash flow was 57,671,000 USD.
Get free Protagonist Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 46,016,000 USD
- Operating income
- -158,127,000 USD
- Net income
- -130,149,000 USD
- Operating cash flow
- 57,671,000 USD